For value investors, the intersection of attractive valuation and sustainable competitive advantage represents the sweet spot. In the current Australian market, several established businesses trade at meaningful discounts to their intrinsic worth while possessing the structural characteristics that protect long-term earnings—moats that shield them from competitive erosion.
Endeavour Group: Scale Advantages in Liquor Retailing
Endeavour Group (ASX: EDV) operates Australia’s largest network of liquor stores, with more than 1,700 outlets across the Dan Murphy’s and BWS brands. The company also holds substantial interests in hotels and electronic gaming machines, operating over 12,000 machines across more than 300 venues.
Morningstar assigns Endeavour a wide economic moat rating, underpinned by scale cost advantages in liquor retailing and intangible assets related to gaming licenses. The company trades at a 35 per cent discount to Morningstar’s fair value estimate of $5.40 per share, offering a current dividend yield of 4.92 per cent fully franked.
Liquor demand is inherently defensive, supported by inflation, population growth, and a structural trend toward premiumisation. With approximately 80 per cent of revenue forecast to come from retail liquor over the next decade, Endeavour offers a rare combination of earnings visibility and attractive valuation.
Sonic Healthcare: Global Diagnostics at a Discount
Sonic Healthcare (ASX: SHL) is a global leader in pathology and diagnostic imaging, with operations spanning Australia, Europe, and North America. The company carries a narrow moat rating and trades at a 20 per cent discount to Morningstar’s fair value estimate of $27 per share.
The healthcare sector has faced persistent weak sentiment despite trading at what UBS describes as an unprecedented price-to-earnings discount. Sonic’s macro-defensive characteristics—its services are essential regardless of economic conditions—make it particularly attractive in the current environment of geopolitical uncertainty and slowing growth.
Amcor: Packaging Resilience Amid Macro Weakness
Amcor (ASX: AMC) reported fiscal 2026 adjusted EPS at the top end of guidance despite a challenging macroeconomic backdrop, particularly in the US, and cost inflation following the Iran conflict. The company’s narrow moat reflects its scale and customer relationships in the global packaging industry.
Morningstar raised its fair value estimate for Amcor by 2 per cent to $85 per share following the results, noting that the balance sheet is in better shape than expected. Net debt to adjusted EBITDA of 3.5 is below the estimate of 3.8, and Morningstar expects this to fall to 2.8 by fiscal 2029.
Shares trade at a 25 per cent discount to fair value, with the market failing to appreciate Amcor’s strategy to expand in high-growth categories such as healthcare and nutrition. With balance-sheet concerns easing, there is scope for dividends to keep growing.
The Moat Imperative in Value Investing
These three companies illustrate a critical principle for value investors: a low valuation alone is insufficient. Each possesses structural competitive advantages—scale, intangible assets, customer stickiness—that protect earnings through economic cycles. Morningstar’s data shows that close to 30 per cent of undervalued ASX shares now carry a narrow or wide moat rating, suggesting the market is offering quality businesses at attractive prices.
The disconnect between market sentiment and business fundamentals has created opportunities for long-term investors willing to look beyond short-term share price reactions. As Morningstar’s analysis of the recent earnings season noted, fair value upgrades outnumbered downgrades by a comfortable margin, yet the average company still experienced a negative same-day share price reaction—a disconnect that disciplined investors can exploit.